Over the last 3 month's JC PENNY stock is off 38%; China based bio-pharma stock, CBPO is up 58%.
CBPO (listed on Nasdaq), for the first 3 quarters, net income was up 190%,over 9 month's a year ago.
China stocks stocks don't have a fiscal cliff, an inactive CONGRESS, and $16 TRILLION national debt.
CBPO has $4 cash per share.
China Biologic Products CBPO is in the bio-pharmaceutical area with over 30 products, with excellent leadership.
China's GDP growth is an robust 8.5% per year, with USA's GDP growth a very weak 1.7% per year.